Sage Journals: Discover world-class research

Free access

Review article

First published 2018-9

A New Perspective on the Nitrate–Phosphodiesterase Type 5 Inhibitor Interaction

Robert A. Kloner, Paul Goggin, Irwin Goldstein [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Open access

Review article

First published 2018-2

The effect of phosphodiesterase-5 inhibitors on cerebral blood flow in humans: A systematic review

Mathilde MH Pauls, Barry Moynihan, Thomas R Barrick [...]

Journal of Cerebral Blood Flow & Metabolism

Free access

Research article

First published 2017-1

Phenanthrenes from Eulophia macrobulbon as Novel Phosphodiesterase-5 Inhibitors

Prapapan Temkitthawon, Kanokwan Changwichit, Nantaka Khorana [...]

Natural Product Communications

Free access

Review article

First published 2009-5

Managing Erectile Dysfunction in Patients With Cardiovascular Diseases: The Efficacy and Safety of Phosphodiesterase-5 Inhibitors

Judy W. M. Cheng, Selamawit R. Berhane

American Journal of Lifestyle Medicine

Open access

Review article

First published 2007

Endothelial Dysfunction,Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives

Angelis Konstantinopoulos, Konstantinos Giannitsas, Spiros Raptis [...]

Drug Target Insights

Retricted access

Article commentary

First published 2024

Phosphodiesterase-5 Inhibitors and Dementia Risk: Confounding by Indication in Real-World Studies

Che-Yuan Wu, Walter Swardfager

Journal of Alzheimer’s Disease

Retricted access

Research article

First published 2008-1

Phosphodiesterase-5 Inhibitors for Lower Urinary Tract Symptoms in Men

Barry J Gales, Mark A Gales

Annals of Pharmacotherapy

Retricted access

Research article

First published 2011-12

Phosphodiesterase Type 5 Inhibitors as Adjunctive Therapy in the Management of Systolic Heart Failure

Ramonna G Cvelich, Sarah C Roberts, Jamie N Brown

Annals of Pharmacotherapy

Retricted access

Review article

First published 2022-9

Effectiveness of phosphodiesterase type 5 inhibitors on the treatment of thin endometrium and pregnancy outcomes: An systematic review

Farnoosh Farahbod, Parham Talebi-Boroujeni, Catherine MT Sherwin [...]

Journal of Endometriosis and Pelvic Pain Disorders

Open access

Case report

First published 2014

Switching from Nitrate Therapy to Ranolazine in Patients with Coronary Artery Disease Receiving Phosphodiesterase Type-5 Inhibitors for Erectile Dysfunction

Dioma U. Udeoji, Ernst R. Schwarz

Clinical Medicine Insights: Case Reports

Search results